logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Stephen T. Oh

Washington University School of Medicine
H指数:45
被引数:9,258

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dual transfusion independence and spleen volume reduction are associated with overall survival in patients with myelofibrosis treated with momelotinib: post hoc analyses of SIMPLIFY-1 and MOMENTUM

双输血独立性及脾脏体积缩小与接受莫美洛替尼治疗的骨髓纤维化患者总生存期相关：SIMPLIFY-1和MOMENTUM试验的事后分析

Annals of Hematology
IF2.4
2026-10-080
OAAI
Francesca Palandri; Nicolaas P. M. Schaap; Jérôme Rey; Nikolas von Bubnoff; Andreas Reiter; Juan Carlos Hernández-Boluda; Timothy Devos; Bethan Psaila; Donal P. McLornan; Catherine Ellis; Shiyuan Zhang; Sunkyung Kim; Stephen T. Oh
TET2 loss triggers ssDNA gap accumulation and heightened PARP inhibitor sensitivity

TET2缺失引发单链DNA缺口积累和增强的PARP抑制剂敏感性

Nature Communications
IF15.7
2026-09-120
OA
Sumedha Agashe; Nidhi Athreya; William Jacobs; Christopher T. Letson; Vladislav O. Sviderskiy; Celia D. Rouault; Yixuan Xie; Carolina Brás-Costa; Emily Zahn; Mary Claire Kendall; Alice Meroni; Matthew Wood; Barbara Soares; Jin Shao; Maggie J. Cox; Luis Francisco Zirnberger Batista; Grant A. Challen; John Krais; Matthew J. Walter; Stephen T. Oh; Benjamin A. Garcia; John Edwards; Priyanka Verma; Alessandro Vindigni
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial

palbociclib联合阿那曲唑治疗内分泌耐药雌激素受体阳性/HER2-negative乳腺癌新辅助治疗反应的生物标志物: 一项2期试验

Nature Communications
IF15.7
2026-01-270
OAAI
Tim Kong; Alex Mabry; Maureen Highkin; Anthony Z. Wang; Jeremy Hoog; Zhanfang Guo; Adrian Gonzales-Gonzales; Shana Thomas; Yingduo Song; Feng Gao; Mateusz Opyrchal; Lindsay Peterson; Foluso Ademuyiwa; Julie Margenthaler; Rebecca Aft; Katherine Glover-Collins; Leslie Nehring; Yu Tao; Souzan Sanati; Ian S. Hagemann; Fouad Boulos; Matthew Holt; Li Ding; Wenge Zhu; Stephen T. Oh; Jianxin Wang; Agnieszka K. Witkiewicz; Erik S. Knudsen; Ron Bose; Jason D. Weber; Matthew Goetz; Donald Northfelt; Jingqin Luo; Cynthia X. Ma
Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study

罗培干扰素alfa-2b在羟基脲不耐受或羟基脲难治性原发性血小板增多症（SURPASS ET）：一项多中心、开放标签、随机、活性对照、III期研究

The Lancet Haematology
IF0
2025-11-030
PRE
Ruben Mesa; Harinder Gill; Lei Zhang; Jie Jin; Keita Kirito; Norio Komatsu; Albert Qin; Zhijian Xiao; Tsewang Tashi; Kazuya Shimoda; Kohshi Ohishi; Suning Chen; Xuelan Zuo; Shuichi Shirane; Yu Hu; Sujiang Zhang; Yi Wang; Katsuto Takenaka; Michiko Ichii; Na Xu; Lee-Yung Shih; Ken-Hong Lim; Sung-Eun Lee; Sung Hwa Bae; Winnie Z Y Teo; Dawn Maze; Stephen T Oh; Prithviraj Bose; Toshiaki Sato; Oleh Zagrijtschuk; Sheena Lin; Weichung Joe Shih; John Mascarenhas; Lucia Masarova
ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera
ACTA HAEMATOLOGICA
IF1.1
2025-11-011
PRE
Mascarenhas, John; Bose, Prithviraj; Hillis, Christopher; Yacoub, Abdulraheem; El Chaer, Firas; Maze, Dawn; Abu-Zeinah, Ghaith; Qin, Albert; Priego, Victor; Tashi, Tsewang; Cerquozzi, Sonia; Babu, Sunil; Foltz, Lynda; Goel, Swati; Bhave, Rupali R.; Lee, Stephanie; Oh, Stephen T.; Reeves, Brandi; Benton, Christopher; Fletcher, Luke; Sirhan, Shireen; Safah, Hana; Salib, Hayman; Villeneuve, Pierre J. A.; Zagrijtschuk, Oleh; Castro, Henry; Masarova, Lucia
A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial

一项多中心研究，旨在评估美国和加拿大特发性血小板增多症患者中ropeginterferon alfa-2b-njft的疗效、安全性和耐受性：EXCEED-ET试验

FRONTIERS IN MEDICINE
IF3
2025-04-170
OA
Masarova, Lucia; Reeves, Brandi N.; El Chaer, Firas; Foltz, Lynda; Tashi, Tsewang; Abu-Zeinah, Ghaith; Lucas, Jennifer; Halpern, Anna B.; Maze, Dawn; Qin, Albert; Safah, Hana; Lan, Fengshuo; O'Connell, Casey L.; Goel, Swati; Rein, Lindsay; Fang, Bruno; How, Joan; Babu, Sunil; Li, Zhuoyan; Cerquozzi, Sonia; Oh, Stephen T.; Hunter, Anthony M.; Podoltsev, Nikolai; Vachhani, Pankit; Yacoub, Abdulraheem; Cunningham, Julia M.; Hillis, Christopher; Otoukesh, Salman; Zagrijtschuk, Oleh; Castro, Henry; Bose, Prithviraj
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial

Pelabresib联合ruxolitinib治疗JAK抑制剂初治骨髓纤维化：一项随机III期试验

NATURE MEDICINE
IF50
2025-03-102
OA
Rampal, Raajit K.; Grosicki, Sebastian; Chraniuk, Dominik; Abruzzese, Elisabetta; Bose, Prithviraj; Gerds, Aaron T.; Vannucchi, Alessandro M.; Palandri, Francesca; Lee, Sung-Eun; Gupta, Vikas; Lucchesi, Alessandro; Oh, Stephen T.; Kuykendall, Andrew T.; Patriarca, Andrea; alvarez-Larran, Alberto; Mesa, Ruben; Kiladjian, Jean-Jacques; Talpaz, Moshe; Scandura, Joseph M.; Lavie, David; Harris, Morgan; Kays, Sarah-Katharina; Li, Qing; Boxhammer, Rainer; Brown, Barbara; Jegg, Anna-Maria; Harrison, Claire N.; Mascarenhas, John
Illustrated capsules from the Advanced Course in Platelet Research
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
IF3.4
2025-02-010
OAAI
Buduo, Christian Andrea Di; Abbonante, Vittorio; Malara, Alessandro; Balduini, Alessandra; Waller, Amie K.; Watson, Steve P.; Martin, Eleyna M.; Bridge, Lloyd; Gibbins, Jonathan; Hers, Ingeborg; Masson, Claire; Eckly, Anita; Poulter, Natalie S.; Martinez-Garcia, Beatriz; Aguila, Sonia; Gresele, Paolo; Momi, Stefania; Amstrong, Paul; Rondina, Matthew; Troitino, Sara; Garcia, Angel; Bastida, Jose M.; Quilez, Ana Marin; Fuentes, Ana Sanchez; Rivera, Jose; Torres-Ruiz, Raul; Ojeda-Walczuk, Paula; Morgan, Neil, V; de la Morena, Belen; Ramaekers, Kato; Tran, My; De Wispelaere, Koen; Freson, Kathleen; Bergmeier, Wolfgang; Greinacher, Andreas; He, Fan; Oh, Stephen; Di Paola, Jorge; Semple, John W.; Lozano, Maria L.; Llamas, Pilar; Ward, Chris
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia

RSK1是骨髓增殖性肿瘤和继发性急性髓系白血病的一个可利用的依赖性。

NATURE COMMUNICATIONS
IF15.7
2025-01-160
OA
Kong, Tim; Laranjeira, Angelo B. A.; Letson, Christopher T.; Yu, Layow; Lin, Shuyang; Fowles, Jared S.; Fisher, Daniel A. C.; Ng, Sherwin; Yang, Wei; He, Fan; Youn, Minyoung; Mark, Kailen; Jose, Ana San; Liu, Jingxian; Kim, Alexander B.; Cox, Maggie J.; Fulbright, Mary C.; Jayanthan, Aarthi; Los, Gerrit; Rentschler, Stacey L.; Ding, Li; Sakamoto, Kathleen M.; Dunn, Sandra E.; Challen, Grant A.; Oh, Stephen T.
A Multicenter, Open-Label, Phase 1 Clinical Trial of AJ1-11095 Administered As Oral Monotherapy in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed By a Type I JAK2 Inhibitor (JAK2i)

一项多中心、开放标签、I期临床试验，评估AJ1-11095以口服单药疗法给药在曾接受过I型JAK2抑制剂（JAK2i）治疗失败的原发性骨髓纤维化（PMF）、真性红细胞增多症后骨髓纤维化（PPV-MF）或原发性血小板增多症后骨髓纤维化（PET-MF）患者中的疗效。

BLOOD
IF23.1
2024-11-050
PRE
Mascarenhas, John O.; Borate, Uma; Bose, Prithviraj; Byrd, John C.; Garcia, Jacqueline S.; Grunwald, Michael R.; Hobbs, Gabriela S.; Hoffman, Ronald; Kuykendall, Andrew T.; Mesa, Ruben A.; Oh, Stephen; Rampal, Raajit; Yacoub, Abdulraheem; Steensma, David P.
Updated Results from the Phase 3 Manifest-2 Study of Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor-Naive Patients with Myelofibrosis

佩拉布雷昔布与鲁索利替尼联合治疗Janus激酶抑制剂初治骨髓纤维化患者的III期Manifest-2研究最新结果

BLOOD
IF23.1
2024-11-052
PRE
Mascarenhas, John O.; Grosicki, Sebastian; Chraniuk, Dominik; Abruzzese, Elisabetta; Bose, Prithviraj; Gerds, Aaron T.; Vannucchi, Alessandro M.; Palandri, Francesca; Lee, Sung-Eun; Gupta, Vikas; Lucchesi, Alessandro; Oh, Stephen; Kuykendall, Andrew T.; Patriarca, Andrea; Alvarez-Larran, Alberto; Mesa, Ruben; Kiladjian, Jean-Jacques; Talpaz, Moshe; Harris, Morgan; Kays, Sarah-Katharina; Li, Qing; Brown, Barbara; Jegg, Anna-Maria; Harrison, Claire; Rampal, Raajit
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages

差异染色质可及性和转录动力学定义乳腺癌亚型及其谱系

NATURE CANCER
IF28.5
2024-10-301
OAAI
Iglesia, Michael D.; Jayasinghe, Reyka G.; Chen, Siqi; Terekhanova, Nadezhda V.; Herndon, John M.; Storrs, Erik; Karpova, Alla; Zhou, Daniel Cui; Al Deen, Nataly Naser; Shinkle, Andrew T.; Lu, Rita Jui-Hsien; Caravan, Wagma; Houston, Andrew; Zhao, Yanyan; Sato, Kazuhito; Lal, Preet; Street, Cherease; Rodrigues, Fernanda Martins; Southard-Smith, Austin N.; da Costa, Andre Luiz N. Targino; Zhu, Houxiang; Mo, Chia-Kuei; Crowson, Lisa; Fulton, Robert S.; Wyczalkowski, Matthew A.; Fronick, Catrina C.; Fulton, Lucinda A.; Sun, Hua; Davies, Sherri R.; Appelbaum, Elizabeth L.; Chasnoff, Sara E.; Carmody, Madelyn; Brooks, Candace; Liu, Ruiyang; Wendl, Michael C.; Oh, Clara; Bender, Diane; Cruchaga, Carlos; Harari, Oscar; Bredemeyer, Andrea; Lavine, Kory; Bose, Ron; Margenthaler, Julie; Held, Jason M.; Achilefu, Samuel; Ademuyiwa, Foluso; Aft, Rebecca; Ma, Cynthia; Colditz, Graham A.; Ju, Tao; Oh, Stephen T.; Fitzpatrick, James; Hwang, E. Shelley; Shoghi, Kooresh I.; Chheda, Milan G.; Veis, Deborah J.; Chen, Feng; Fields, Ryan C.; Gillanders, William E.; Ding, Li
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response
LEUKEMIA
IF13.4
2024-10-040
PRE
Jacoby, Meagan A.; Duncavage, Eric D.; Khanna, Ajay; Chang, Gue Su; Srivatsan, Sridhar Nonavinkere; Miller, Christopher A.; Gao, Feng; Robinson, Josh; Shao, Jin; Fulton, Robert S.; Fronick, Catrina C.; O'Laughlin, Michelle; Heath, Sharon E.; Brendel, Kimberly; Chavez, Monique; Dipersio, John F.; Abboud, Camille N.; Stockerl-Goldstein, Keith; Westervelt, Peter; Cashen, Amanda; Pusic, Iskra; Oh, Stephen T.; Welch, John S.; Wells, Denise A.; Loken, Michael R.; Uy, Geoffrey L.; Walter, Matthew J.
Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies
VALUE IN HEALTH
IF6
2024-05-014
PRE
Hudgens, Stacie; Verstovsek, Srdan; Floden, Lysbeth; Harrison, Claire N.; Palmer, Jeanne; Gupta, Vikas; McLornan, Donal; McMullin, Mary Frances; Kiladjian, Jean-Jacques; Foltz, Lynda; Platzbecker, Uwe; Fox, Maria Laura; Mead, Adam J.; Ross, David M.; Oh, Stephen T.; Perkis, Andrew A.; Leahy, Michael F.; Deheshi, Samineh; Donahue, Rafe; Klencke, Barbara J.; Mesa, Ruben A.
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results

添加parsaclisib治疗骨髓纤维化和对ruxolitinib的次优反应患者的2期研究: 最终结果

BLOOD ADVANCES
IF7.1
2024-03-184
OAAI
Yacoub, Abdulraheem; Borate, Uma; Rampal, Raajit K.; Ali, Haris; Wang, Eunice S.; Gerds, Aaron T.; Hobbs, Gabriela; Kremyanskaya, Marina; Winton, Elliott; O'Connell, Casey; Goel, Swati; Oh, Stephen T.; Schiller, Gary; McCloskey, James; Palmer, Jeanne; Holmes, Houston; Hager, Steven; Assad, Albert; Erickson-Viitanen, Susan; Zhou, Feng; Daver, Naval

研究方向

暂未获取到该数据
R
Ruben A. Mesa
H 指数:96论文数:1,281被引数:4.5万
A
Aaron T. Gerds
H 指数:40论文数:726被引数:6,771
S
Srđan Verstovšek
H 指数:114论文数:1,617被引数:5.8万
J
Jean‐Jacques Kiladjian
H 指数:71论文数:760被引数:2.8万
V
Vikas Gupta
H 指数:75论文数:896被引数:2.4万
C
Claire Harrison
H 指数:80论文数:849被引数:3.5万
P
Prithviraj Bose
H 指数:51论文数:723被引数:1.0万
J
Jason Gotlib
H 指数:83论文数:695被引数:3.1万
A
Alessandro M. Vannucchi
H 指数:109论文数:1,203被引数:5.3万
M
Moshe Talpaz
H 指数:124论文数:1,274被引数:7.3万